DNA Health, LLC (NJ) v. Liv Health LLC

CourtDistrict Court, E.D. Kentucky
DecidedMarch 28, 2024
Docket5:22-cv-00121
StatusUnknown

This text of DNA Health, LLC (NJ) v. Liv Health LLC (DNA Health, LLC (NJ) v. Liv Health LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DNA Health, LLC (NJ) v. Liv Health LLC, (E.D. Ky. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY CENTRAL DIVISION LEXINGTON

) DNA HEALTH, LLC (NJ), ) ) Civil No. 5:22-cv-00121-GFVT Plaintiff, ) ) v. ) MEMORANDUM OPINION ) & LIV HEALTH LLC, et al., ) ORDER ) Defendants. ) ) *** *** *** *** This matter is before the Court on Counter-Defendant Michael Antonelli’s Motion to Dismiss the Counter-Plaintiff’s First Amended Counterclaims. [R. 68.] Plaintiff DNA Health, LLC (NJ) and its founder Michael Antonelli originated this action in 2022 when they filed a complaint against a number of defendants whom DNA Health New Jersey and Mr. Antonelli allege breached numerous contractual agreements. In February 2023, Defendants Liv Health LLC and Tailor Made Health LLC filed a counterclaim against Mr. Antonelli. Following Mr. Antonelli’s first motion to dismiss, Liv Health and Tailor Made filed an Amended Counterclaim. Mr. Antonelli now moves to dismiss Liv Health and Tailor Made’s Amended Counterclaim. Because the pleading stage is about the availability of a claim, not its merits, Mr. Antonelli’s motion to dismiss will be DENIED. I

This litigation began when a business venture went wrong.1 Michael Antonelli sells nutraceuticals, which are herbal, dietary supplements. [R. 1 at 4.] To market nutraceuticals to

1 For consistency and clarity, these background facts are adopted from a previous Memorandum Opinion and Order issued by this Court. [See R. 78 at 1-3.] doctors, Mr. Antonelli created DNA Health, an LLC organized under New Jersey law. Id. In July 2021, DNA Health entered into a ten-million-dollar deal with Liv Health and Tailor Made to purchase BPC-157, a nutraceutical. [R. 1 at 4.] As part of the bargain, DNA Health signed a secured note and granted Liv Health a security interest in many of its assets. [R. 38 at 5; R. 1-5;

R. 1-6.] DNA Health also signed marketing and consulting agreements with Defendants Deal Media, LLC, and Tru Diagnostics, Inc., to assist with the business venture. [R. 1-3; R. 1-4.] Before starting DNA Health, Mr. Antonelli worked for BioTE Medical. [R. 25-1 at 5.] Shortly after DNA Health signed its BPC-157 purchase agreement, BioTE Medical sued Mr. Antonelli and DNA Health, claiming that Mr. Antonelli violated a non-compete agreement that prevented him from selling nutraceuticals to its customers. [R. 1 at 5; R. 25-1 at 8.] In January 2022, a Texas court enjoined Mr. Antonelli and DNA Health from selling BPC-157 in competition with BioTE. [R. 1 at 5; R. 25-1 at 8; R. 58-1 at 4.] In early February 2022, Mr. Antonelli spoke with Defendant Jeremy Delk, a manager of Tailor Made, about the Texas injunction. [R. 27 at 3.] With a payment looming on February 15,

Mr. Antonelli admitted that the injunction would likely cause DNA Health to be unable to pay. [R. 38 at 6.] On February 3, Mr. Delk sent Mr. Antonelli an email regarding these conversations. [R. 1-8.] Mr. Delk wrote: Per our conversation then, as well as our calls yesterday and notice of fact that DNA Health, LLC will not be paying its note and is trading insolvent, Liv Health llc [sic] hereby accepts this notice and Liv Health, LLC will now take all actions afforded to it in order to remedy this event default as laid out in section 8 of the Secured Promissory Note, the Continuing Security Agreement and the APA.

Id. at 2. Mr. Antonelli and DNA Health’s attorney disagreed with this assessment. [R. 1-9.] Counsel emailed Mr. Delk on February 3 and claimed that “[m]y client is not in default” and “he has until Friday, February 25th to make his payment . . . given the 10 day grace period . . . .” Id. at 2. Despite Mr. Antonelli’s position, Defendant Michael Scanlon formed a second DNA Health, LLC, on February 4, under Kentucky law. [R. 1-10.] Mr. Antonelli alleges that the

Defendants began soliciting his clients as early as February 7. [R. 38 at 7.] On March 8, Mr. Delk participated in a deposition related to the Texas litigation. Id. at 8; [R. 1-11.] Mr. Delk claimed that Liv Health had control of DNA New Jersey’s operations and assets. [R. 38 at 8.] Mr. Antonelli alleges that the Defendants essentially continued to sell DNA New Jersey’s products via the new DNA Kentucky entity. Id. at 9. On May 11, 2022, DNA New Jersey filed its lawsuit against DNA Kentucky, Mr. Delk, Mr. Scanlon, and several of the entities associated with the BPC-157 purchase and marketing arrangement. [R. 1.] DNA New Jersey claims that the Defendants breached the terms of the secured promissory note, the security agreement, the asset purchase agreement, the Deal Media marketing agreement, and the Tru Diagnostics consulting agreement. Id. at 8–10. On August

22, 2022, DNA New Jersey amended the complaint to allege a claim for unfair competition and trademark infringement in violation of the Lanham Act.2 [R. 38.] Subsequently, the Court granted leave for Liv Health and Tailor Made to file a counterclaim against Mr. Antonelli. [R. 62; see also R. 63.] Following Mr. Antonelli’s motion to dismiss their original counterclaim, Liv Health and Tailor Made filed an Amended Counterclaim, which appeared to fix many of the deficiencies that plagued their original counterclaim. [R. 68.] Mr. Antonelli then moved, pursuant to Rule 12(b)(6), to dismiss this Amended Counterclaim. [R. 69.] The Court turns now to that pending motion.

2 The Court considered DNA New Jersey’s claims when it issued a previous Memorandum Opinion and Order denying four separate motions to dismiss. [R. 78.] II To survive a motion to dismiss under Rule 12(b)(6), a complaint must contain sufficient factual allegations to state a claim that is plausible on its face. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). The plaintiff must provide grounds for his requested relief that are more than mere

labels and conclusions. Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007). A “formulaic recitation of the elements of cause of action will not do.” Id. The complaint must enable a court to draw a “reasonable inference that the defendant is liable for the misconduct alleged.” Iqbal, 556 U.S. at 678. To be plausible, a claim need not be probable, but the complaint must show “more than a sheer possibility that a defendant has acted unlawfully.” Id. A complaint that pleads facts that are consistent with but not demonstrative of the defendant’s liability “stops short of the line between possibility and plausibility of ‘entitlement to relief.’” Id. (quoting Twombly, 550 U.S. at 556). The moving party bears the burden of persuading a trial court that the plaintiff fails to state a claim. Bangura v. Hansen, 434 F.3d 487, 498 (6th Cir. 2006).

To review a Rule 12(b)(6) motion, courts construe the complaint “in the light most favorable to the plaintiff” and make “all inferences in favor of the plaintiff.” DirecTV, Inc. v. Treesh, 487 F.3d 471, 476 (6th Cir. 2007). The Court, however, “need not accept as true legal conclusions or unwarranted factual inferences.” Id. (quoting Gregory v. Shelby Cnty., 220 F.3d 433, 446 (6th Cir. 2000)). Generally, this inquiry does not look beyond the recitations set forth in the complaint itself. Gavitt v. Born, 835 F.3d 623, 640 (6th Cir. 2016). To consider material outside of the pleadings, district courts must treat a motion as brought under Rule 56, which applies to summary judgment, and accord all parties an opportunity to supplement the record. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Ashland, Inc. v. Oppenheimer & Co., Inc.
648 F.3d 461 (Sixth Circuit, 2011)
Stringer v. Wal-Mart Stores, Inc.
151 S.W.3d 781 (Kentucky Supreme Court, 2004)
Ann Taylor, Inc. v. Heritage Insurance Services, Inc.
259 S.W.3d 494 (Court of Appeals of Kentucky, 2008)
Republic Bank & Trust Co. v. Bear, Stearns & Co.
707 F. Supp. 2d 702 (W.D. Kentucky, 2010)
Bangura v. Hansen
434 F.3d 487 (Sixth Circuit, 2006)
Christian Kreipke v. Wayne State University
807 F.3d 768 (Sixth Circuit, 2015)
David Gavitt v. Bruce Born
835 F.3d 623 (Sixth Circuit, 2016)
PCR Contractors, Inc. v. Danial
354 S.W.3d 610 (Court of Appeals of Kentucky, 2011)
Jones v. Marquis Terminal, Inc.
454 S.W.3d 849 (Court of Appeals of Kentucky, 2014)
Superior Steel, Inc. v. Ascent at Roebling's Bridge, LLC
540 S.W.3d 770 (Missouri Court of Appeals, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
DNA Health, LLC (NJ) v. Liv Health LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dna-health-llc-nj-v-liv-health-llc-kyed-2024.